# Del Monte share price today (Del Monte Corporation, DMC)

> Del Monte Corporation's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. DMC · Materials · Agricultural Inputs · data as of 4 November 2026. Page: https://www.sectoralpha.in/us/stocks/dmc

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Getting worse, from the last 12 quarters
- Price: $28.70 (−23.0% in a year)
- P/E: 16.9×, over 1 year
- Revenue (Jun 2026): $1.2 B (+3.1% on a year ago)
- Profit (Jun 2026): $21.2 M (−62.7% on a year ago)
- Operating margin: 3.9% (−1.8 points on a year ago)
- ROE: 5%, FY25
- ROIC: 4.5%, against a 4.2% cost of capital: +0.3 points

Biggest thing to watch: margins are the best this company has ever reported. Every ratio looks better at a record, so the story depends on margins staying high. ## What is the Del Monte share price today? Del Monte Corporation's share price was $28.70 at the close on 4 November 2026. That is 16.1% below its average price over the last 200 trading days. In the last 52 weeks it traded between $27 and $43, and at that close it sat 9% of the way up from that low. Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 2 weeks running. Over the last 1 year the share price moved −15% while the S&P 500 moved +23%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 23 October 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Del Monte pay? Del Monte Corporation paid $1.20 per share over the last four reported quarters. The most recent declaration was $0.30 for Jun 2026. At today's price of $28.70 that is a yield of 4.18%, based on dividends already paid, not a forecast. ## Which stock lists is Del Monte on? Del Monte is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Del Monte profitable? Del Monte Corporation earned $21.2 M of net profit in the Jun 2026 quarter, −62.7% on the same quarter a year earlier. Full-year FY25 profit was $90.7 M. Over 4 years profit has grown 3.2% a year on average. That is 1.7% of the quarter's revenue. The same quarter a year earlier earned $56.8 M. 2 of the last 12 reported quarters were loss-making. For the full year, FY25 profit was $90.7 M (−36.2% on the year before). Why profit moved: revenue changed +3.1% on a year earlier and the margin moved −1.8 percentage points. Sales did the work, and the margin was about flat. On average over the last four quarters, profit changed −60.8% and revenue −0.3%. Profit is growing slower than sales: rising costs are taking part of the growth. ## How much revenue does Del Monte make, and is it growing? Del Monte Corporation reported $1.2 B of revenue in the Jun 2026 quarter, +3.1% on the same quarter a year earlier. Over 4 years it has grown 0.4% a year on average. The last full year, FY25, came in at $4.3 B. The last four reported quarters add to $4.3 B. FY25 revenue was $4.3 B, +1.0% on the year before. Recent pace: the last four quarters grew −0.3% on average, against 0.4% a year over the longer run, so this year is growing at about the same pace as its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew −0.2%, against +0.5% a year over the last 8 quarters (stabilising). ## How much of every $100 of sales does Del Monte keep? Del Monte Corporation's operating margin was 3.9% in the Jun 2026 quarter, 1.8 percentage points lower than the same quarter a year ago. Its latest full-year margin is the highest it has ever reported. Across 5 years it has been between 2.5% and 4.2%. The latest quarter is within that range. Across 5 years it has been between 2.5% and 4.2%, and FY25's 4.2% is the highest of them. Why the margin moved: operating margin changed −1.8 percentage points on the year while gross margin changed −0.3 points. So the drop came mostly from costs below the gross margin, such as staff and overheads, measured against sales. When margins are at a record, every ratio built on profit looks better than usual, so watch whether they hold. ## Is Del Monte's profit turning into cash? Over the last 3 years, 148% of Del Monte Corporation's reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $245 M of operating cash against $90.7 M of profit. After $63.8 M of spending on assets, $181 M was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does Del Monte's cash go? Del Monte Corporation does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $173 M on assets over the last 3 years. Averaged over those years that is 1.3% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $173 M over the last 3 years. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Del Monte's P/E ratio, and how does it compare with its own history? Del Monte Corporation's P/E is 16.9×, with too little history to compare. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved −36.5% while the price moved −23.0%. The price did better than earnings, which pushed the multiple up within its own range. In short: there is too little history to say whether the multiple is high or low for this company, so the earnings trend underneath matters more than the multiple. ## Is the Del Monte business getting better or worse? Del Monte Corporation's business is getting worse. Revenue, profit and EPS growth are shrinking: revenue growth is −0.2% in the latest quarter, against +1.3% at its best in 12 quarters, with ROCE steady at 5.8%. This is based on 12 quarters of 4 measures. Why it matters: falling lines mean any ratio below that looks low should be read with that direction in mind. ## How much does Del Monte earn on its capital? Del Monte Corporation earned a ROE of 5% in FY25. That is up from a low of −1% in FY23. Its return on capital used (ROIC) is 0.3 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 2.1% net margin and 1.41× asset turnover (sales divided by assets). Why the return is what it is (FY25): a 2.1% net margin × 1.41× asset turnover × 1.51× leverage (assets divided by equity) ≈ 4.5% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: 4.5% − 4.2% = +0.3 percentage points. The 4.2% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Positive but thin: it creates value with little room for error. The 4.5% ROIC above is the latest reading, as reported. The yearly chart below shows FY25 at 5.5%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does Del Monte have too much debt? Del Monte Corporation has total debt of $595 M against shareholder equity of $2.0 B as of Jun 2026, so its debt is 0.29× its equity, which is very little. Year by year, that ratio went from 0.39 in FY21 to 0.17 in FY25. So the returns on this page come from the business, not from borrowed money. ## What is the Del Monte shareholding pattern? 4.7% of Del Monte Corporation's tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 4.4 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Del Monte from balance-sheet trouble? For Del Monte Corporation, the Z-score is 2.98. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is in the grey area between the two. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 2.98 is in the grey area, neither clearly safe nor clearly in trouble. ## How does Del Monte rank in its industry? 39.9 out of 100, rank 7 of 11 in Agricultural Inputs, with 75% of the evidence available. Del Monte Corporation scores 39.9 out of 100 against the 11 companies it is compared with in Agricultural Inputs, ranking 7. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 11.2 + 9.2 + 9.4 + 10.1 = 39.9. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Del Monte compared with? Del Monte ranks 7 of 11 Agricultural Inputs companies on the 4-Factor Sector Score, with 39.9 out of 100. 1. [CF Industries Holdings, Inc.](https://www.sectoralpha.in/us/stocks/cf) CF · quiet · Sector-leading setup · 85% evidence 82.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 31.4/35 · Revenue 20% · Profit 61.2% · Operating margin change 15.3 points · 95% evidence Capital efficiency 20.4/25 · ROCE 20.8% · Operating margin 49.3% · 76% evidence Valuation 15.9/20 · P/E 7.9× · PEG 0.24 · 65% evidence Relative strength 15.0/20 · Lead over its industry 26.8% · Lead over S&P 500 -4.1% · 1 year 36.1% · 100% evidence · 4 of 12 weeks ahead Exact sum: 31.4 + 20.4 + 15.9 + 15 = 82.7 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 2. [CVR Partners, LP](https://www.sectoralpha.in/us/stocks/uan) UAN · quiet · Most evidence points up · 85% evidence 79.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 32.2/35 · Revenue 17.3% · Profit 83% · Operating margin change 14.8 points · 95% evidence Capital efficiency 18.8/25 · ROCE 20.2% · Operating margin 42.4% · 76% evidence Valuation 16.2/20 · P/E 7.4× · PEG 0.06 · 65% evidence Relative strength 12.1/20 · Lead over its industry 18.4% · Lead over S&P 500 -10.4% · 1 year 12.4% · 100% evidence · 5 of 12 weeks ahead Exact sum: 32.2 + 18.8 + 16.2 + 12.1 = 79.3 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 3. [Nutrien Ltd.](https://www.sectoralpha.in/us/stocks/ntr) NTR · turning · Most evidence points up · 75% evidence 67.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.1/35 · Revenue 9.1% · Profit 73.3% · Operating margin change -0.3 points · 95% evidence Capital efficiency 14.5/25 · ROCE 8.7% · Operating margin 17.5% · 76% evidence Valuation 10.3/20 · P/E 12.7× · PEG n/a · 15% evidence Relative strength 17.4/20 · Lead over its industry 29.3% · Lead over S&P 500 -2.3% · 1 year 26.7% · 100% evidence · 6 of 12 weeks ahead Exact sum: 25.1 + 14.5 + 10.3 + 17.4 = 67.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [The Scotts Miracle-Gro Company](https://www.sectoralpha.in/us/stocks/smg) SMG · turning · Most evidence points up · 85% evidence 66.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.1/35 · Revenue 1.3% · Profit 39.6% · Operating margin change -2.4 points · 95% evidence Capital efficiency 17.4/25 · ROCE 22.8% · Operating margin 16.8% · 76% evidence Valuation 11.2/20 · P/E 55× · PEG 1.15 · 65% evidence Relative strength 19.6/20 · Lead over its industry 35.9% · Lead over S&P 500 2.6% · 1 year 19% · 100% evidence · 1 of 12 weeks ahead Exact sum: 18.1 + 17.4 + 11.2 + 19.6 = 66.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [ICL Group Ltd](https://www.sectoralpha.in/us/stocks/icl) ICL · quiet · Evidence leans up · 85% evidence 57.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.5/35 · Revenue 10.9% · Profit -16.9% · Operating margin change 2.6 points · 95% evidence Capital efficiency 11.9/25 · ROCE 8.1% · Operating margin 12.5% · 76% evidence Valuation 14.7/20 · P/E 21.1× · PEG 0.11 · 65% evidence Relative strength 10.8/20 · Lead over its industry 5.9% · Lead over S&P 500 -20% · 1 year -18.8% · 100% evidence · 0 of 12 weeks ahead Exact sum: 20.5 + 11.9 + 14.7 + 10.8 = 57.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Intrepid Potash, Inc.](https://www.sectoralpha.in/us/stocks/ipi) IPI · quiet · Evidence leans down · 67% evidence 46.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 17.3/35 · Revenue 7.8% · Profit n/a · Operating margin change -0.8 points · 71% evidence Capital efficiency 7.1/25 · ROCE 2.9% · Operating margin 2.5% · 76% evidence Valuation 10.0/20 · P/E 16.4× · PEG n/a · 15% evidence Relative strength 12.3/20 · Lead over its industry 12.4% · Lead over S&P 500 -15.7% · 1 year 24.1% · 100% evidence · 3 of 12 weeks ahead Exact sum: 17.3 + 7.1 + 10 + 12.3 = 46.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. Del Monte Corporation this page DMC · quiet · Evidence leans down · 75% evidence 39.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 11.2/35 · Revenue -0.2% · Profit -77.3% · Operating margin change -1.8 points · 95% evidence Capital efficiency 9.2/25 · ROCE 5.6% · Operating margin 3.9% · 76% evidence Valuation 9.4/20 · P/E 40.9× · PEG n/a · 15% evidence Relative strength 10.1/20 · Lead over its industry 3.2% · Lead over S&P 500 -22.7% · 1 year -23% · 100% evidence · 1 of 12 weeks ahead Exact sum: 11.2 + 9.2 + 9.4 + 10.1 = 39.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [The Mosaic Company](https://www.sectoralpha.in/us/stocks/mos) MOS · basing · Evidence leans down · 75% evidence 39.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 9.8/35 · Revenue 8.8% · Profit -168.1% · Operating margin change -8.2 points · 95% evidence Capital efficiency 6.6/25 · ROCE 2.5% · Operating margin -0.1% · 76% evidence Valuation 10.6/20 · P/E 9× · PEG n/a · 15% evidence Relative strength 12.9/20 · Lead over its industry 12.1% · Lead over S&P 500 -15.9% · 1 year -15.5% · 100% evidence · 3 of 12 weeks ahead Exact sum: 9.8 + 6.6 + 10.6 + 12.9 = 39.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Corteva, Inc.](https://www.sectoralpha.in/us/stocks/ctva) CTVA · basing · Most evidence points down · 75% evidence 33.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 11.8/35 · Revenue -40.3% · Profit -132.5% · Operating margin change -14.4 points · 95% evidence Capital efficiency 12.3/25 · ROCE 11.6% · Operating margin 12.8% · 76% evidence Valuation 9.1/20 · P/E 41.9× · PEG n/a · 15% evidence Relative strength 0.0/20 · Lead over its industry -77.6% · Lead over S&P 500 -83.6% · 1 year -80.9% · 100% evidence · 3 of 12 weeks ahead Exact sum: 11.8 + 12.3 + 9.1 + 0 = 33.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [FMC Corporation](https://www.sectoralpha.in/us/stocks/fmc) FMC · quiet · Most evidence points down · 75% evidence 24.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 4.3/35 · Revenue -21.3% · Profit -2802.9% · Operating margin change -3.7 points · 95% evidence Capital efficiency 6.2/25 · ROCE 1.5% · Operating margin 11.8% · 76% evidence Valuation 8.8/20 · P/E 52.7× · PEG n/a · 15% evidence Relative strength 5.1/20 · Lead over its industry -35.9% · Lead over S&P 500 -52.6% · 1 year -54.1% · 100% evidence · 1 of 12 weeks ahead Exact sum: 4.3 + 6.2 + 8.8 + 5.1 = 24.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [Glass House Brands Inc.](https://www.sectoralpha.in/us/stocks/glas) GLAS · quiet · Most evidence points down · 75% evidence 17.7 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Jun 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Agricultural Inputs](https://www.sectoralpha.in/us/sectors/agricultural-inputs), all 11 compared on one page. ## Which companies are close to Del Monte in size? Del Monte is the 7th largest of 11 Agricultural Inputs companies on Sector Alpha by market value (scores of 4 November 2026). Just above it: The Mosaic Company, ICL Group and The Scotts Miracle-Gro Company. Just below it: CVR Partners, LP, FMC Corporation and Intrepid Potash, Inc. ### Agricultural Inputs companies close in size

1. [The Mosaic Company](https://www.sectoralpha.in/us/stocks/mos) $6.9 billion
2. [ICL Group Ltd](https://www.sectoralpha.in/us/stocks/icl) $5.9 billion
3. [The Scotts Miracle-Gro Company](https://www.sectoralpha.in/us/stocks/smg) $3.9 billion
4. Del Monte Corporation $1.4 billion
5. [CVR Partners, LP](https://www.sectoralpha.in/us/stocks/uan) $1.2 billion
6. [FMC Corporation](https://www.sectoralpha.in/us/stocks/fmc) $999 million
7. [Intrepid Potash, Inc.](https://www.sectoralpha.in/us/stocks/ipi) $412 million

[All 11 Agricultural Inputs companies, largest first](https://www.sectoralpha.in/us/sectors/agricultural-inputs#all-companies)

### Companies close in size in other industries

1. [Clarivate Plc](https://www.sectoralpha.in/us/stocks/clvt) $1.4 billion · Information Technology Services
2. [Grocery Outlet Holding Corp.](https://www.sectoralpha.in/us/stocks/go) $1.4 billion · Grocery Stores
3. Del Monte Corporation $1.4 billion
4. [Allient Inc.](https://www.sectoralpha.in/us/stocks/alnt) $1.4 billion · Electronic Components
5. [Universal Insurance Holdings, Inc.](https://www.sectoralpha.in/us/stocks/uve) $1.3 billion · Insurance - Property & Casualty

## What else do people ask about Del Monte? ### What were Del Monte's latest quarterly results? Del Monte Corporation reported revenue of $1.2 B and net profit of $21.2 M for the Jun 2026 quarter. Revenue rose 3.1% and profit fell 62.7% compared with a year earlier. Earnings per share were $0.44. The operating margin was 3.9%, 1.8 percentage points lower than a year earlier (as of 4 November 2026). ### What is Del Monte's market cap? Del Monte Corporation's market capitalisation is $1.4 B at a stock price of $28.70. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026). ### How is Del Monte performing? Del Monte Corporation's latest readings are below. In its latest quarter, revenue rose 3.1% and profit fell 62.7% compared with a year earlier. Over the past 13 weeks it has done worse than the S&P 500, for 2 weeks running. This describes what the data did, not a rating (as of 4 November 2026). ### Will Del Monte's stock price go up? This page does not forecast Del Monte Corporation's stock price. What it shows instead: the stock price is $28.70. Nobody can reliably say which way a price will move, and this site does not try (as of 4 November 2026). ### Does Del Monte have too much debt? Del Monte Corporation has a moderate amount of debt: its debt is 0.33× its equity. A year-by-year history of its borrowings is not in our data, so this uses the latest reading. Keep that borrowing in mind when reading the returns on this page (as of 4 November 2026). ### Where is Del Monte in its business cycle? Del Monte Corporation's FY25 operating margin was 4.2%, against a 5-year range of 2.5% to 4.2%: the top of its range, a record year. When profit is at a record, every ratio looks better than usual, and the story depends on margins staying high. The latest quarter was 3.9%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 4 November 2026). ### What could break the Del Monte story? Biggest thing to watch: margins are the best this company has ever reported. Every ratio looks better at a record, so the story depends on margins staying high. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026). ### Is Del Monte a stock worth studying right now? What the numbers show: Del Monte Corporation's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026). This is research, not advice. We’re not SEBI-registered.